Embed

Academic

Authors

Tarek Sahmoud

Tarek Sahmoud,Universität Basel,Oncology,Anatomy,Neuroscience

Edit

Tarek Sahmoud

Universität Basel

Publications: 57 | Citations: 1222

Fields: Oncology, Anatomy, Neuroscience

Collaborated with 301 co-authors from 1993 to 2011 | Cited by 4709 authors

Cumulative Annual

Sort by:

Publications (57)

BibTeX | RIS | RefWorks Download

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer (Citations: 1)

, , , , , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 125, no. 2, pp. 447-455, 2011

Everolimus in Subependymal Giant Cell Astrocytomas (SEGA) Associated with Tuberous Sclerosis Complex (TSC): Results of EXIST1, a Double-Blind Placebo-controlled Phase III Trial

, , , , , , , , ,

Journal: European Journal of Cancer - EUR J CANCER , vol. 47, pp. 4-5, 2011

Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO2 Phase III Trial

, , , , , , , , ,

Journal: European Journal of Cancer - EUR J CANCER , vol. 47, pp. 6-7, 2011

Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issues

, , , , , , , , ,

Journal: European Journal of Cancer - EUR J CANCER , vol. 47, no. 15, pp. 2249-2255, 2011

P09.4 Everolimus therapy shows dose proportionality in patients with tuberous sclerosis complex (TSC) treated for subependymal giant-cell astrocytomas (SEGAs)

, , , , ,

Journal: European Journal of Paediatric Neurology - EUR J PAEDIATR NEUROL , vol. 15, pp. S69-S69, 2011

Sort by:

Citations (1222 times by 1184 publications)

Small-cell lung cancer (Citations: 33)

, ,

Journal: Lancet , vol. 378, no. 9804, pp. 1741-1755, 2011

Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study (Citations: 5)

, , , , , , , ,

Journal: Breast Cancer Research and Treatment - BREAST CANCER RES TREAT , vol. 125, no. 3, pp. 869-878, 2011

Detection of Lymph Node Involvement by Cytokeratin Immunohistochemistry is an Independent Prognostic Factor After Curative Resection of Esophageal Cancer (Citations: 2)

, , , , , ,

Journal: Journal of Gastrointestinal Surgery - J GASTROINTEST SURG , vol. 15, no. 1, pp. 29-37, 2011

Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation Therapy (Citations: 1)

, , , , , ,

Journal: Annals of Surgical Oncology - ANNALS SURG ONCOLOGY , vol. 18, no. 2, pp. 551-558, 2011

Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas (Citations: 1)

, , , , , ,

Journal: Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL , vol. 67, no. 3, pp. 621-627, 2011

Comments

Co-authors (301)

Journals (22)

Keywords (135)

Tarek Sahmoud,Universität Basel,Oncology,Anatomy,Neuroscience

Publications (57)

BibTeX | RIS | RefWorks Download

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer (Citations: 1)

Everolimus in Subependymal Giant Cell Astrocytomas (SEGA) Associated with Tuberous Sclerosis Complex (TSC): Results of EXIST1, a Double-Blind Placebo-controlled Phase III Trial

Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO2 Phase III Trial

Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issues

P09.4 Everolimus therapy shows dose proportionality in patients with tuberous sclerosis complex (TSC) treated for subependymal giant-cell astrocytomas (SEGAs)

Citations (1222 times by 1184 publications)

Small-cell lung cancer (Citations: 33)

Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study (Citations: 5)

Detection of Lymph Node Involvement by Cytokeratin Immunohistochemistry is an Independent Prognostic Factor After Curative Resection of Esophageal Cancer (Citations: 2)

Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation Therapy (Citations: 1)

Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas (Citations: 1)


	View FAQ about top research areas and Fields of study

Tarek Sahmoud,Universität Basel,Oncology,Anatomy,Neuroscience

Publications (57) BibTeX | RIS | RefWorks Download

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer (Citations: 1)

Small-cell lung cancer (Citations: 33)

Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study (Citations: 5)

Detection of Lymph Node Involvement by Cytokeratin Immunohistochemistry is an Independent Prognostic Factor After Curative Resection of Esophageal Cancer (Citations: 2)

Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation Therapy (Citations: 1)

Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas (Citations: 1)

Publications (57)

BibTeX | RIS | RefWorks Download